Published in Can Fam Physician on April 01, 2007
Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial. Can Respir J (2009) 1.47
Examining asthma quality of care using a population-based approach. CMAJ (2008) 1.17
Real-life asthma care in Canada. Can Respir J (2009) 0.90
Asthma management made too SIMPLE. Can Fam Physician (2010) 0.88
Enablers of Physician Prescription of a Long-Term Asthma Controller in Patients with Persistent Asthma. Can Respir J (2016) 0.77
Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group. Can Respir J (2009) 0.75
Contemporaneous International Asthma Guidelines Present Differing Recommendations: An Analysis. Can Respir J (2016) 0.75
Asthma management in the real world: The perils of simplicity. Can Fam Physician (2010) 0.75
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J (2000) 5.54
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (1990) 3.40
Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J (2006) 3.27
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
Acute asthma in adults: a review. Chest (2004) 2.51
The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest (2002) 2.38
Control of asthma in Canada: failure to achieve guideline targets. Can Respir J (2001) 2.26
Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol (2003) 2.04
Use of inhaled medications and urgent care services. Study of Canadian asthma patients. Can Fam Physician (1999) 1.20
Evaluation of a program aimed at increasing referrals for asthma education of patients consulting at the emergency department for acute asthma. Chest (2004) 1.16
Measuring health-related quality of life in adults during an acute asthma exacerbation. Chest (2004) 1.06
Effects of increased primary care access on process of care and health outcomes among patients with asthma who frequent emergency departments. Am J Med (2004) 1.01
Asthma prevention and management guidelines. Ministry of Health and Welfare, Japan. Int Arch Allergy Immunol (2000) 0.87
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
Does this dyspneic patient in the emergency department have congestive heart failure? JAMA (2005) 6.14
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59
Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med (2014) 3.50
Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J (2006) 3.27
Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23
Delay in diagnosis among hospitalized patients with active tuberculosis--predictors and outcomes. Am J Respir Crit Care Med (2002) 3.10
Economic burden of asthma: a systematic review. BMC Pulm Med (2009) 3.10
Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health (2012) 3.01
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol (2003) 2.98
Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med (2011) 2.80
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med (2014) 2.53
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2003) 2.43
Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults. Can Respir J (2010) 2.42
Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries. Value Health (2005) 2.32
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med (2010) 2.31
Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma? CMAJ (2002) 2.30
The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ (2006) 2.20
Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ (2005) 2.12
Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med (2014) 2.00
Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J (2012) 1.96
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol (2006) 1.91
Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85
Statins in COPD: a systematic review. Chest (2009) 1.82
Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax (2011) 1.80
A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada. Environ Health Perspect (2009) 1.77
Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med (2002) 1.73
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med (2006) 1.71
Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization. Can Respir J (2009) 1.70
Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med (2006) 1.68
Risk factors of hospitalization and readmission of patients with COPD exacerbation--systematic review. Int J Chron Obstruct Pulmon Dis (2007) 1.67
Targeting lung attacks. Thorax (2011) 1.53
Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study. Chest (2010) 1.49
Obesity and asthma: a specific phenotype? Chest (2008) 1.47
Asthma in pregnancy. BMJ (2007) 1.47
Allergen-derived T cell peptides and late asthmatic responses. Am J Respir Crit Care Med (2004) 1.40
A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J (2012) 1.39
The value of thoracic computed tomography scans in clinical diagnosis: a prospective study. Can Respir J (2006) 1.39
Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study. Thorax (2013) 1.39
The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest (2006) 1.38
Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest (2006) 1.38
The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada. Can Respir J (2005) 1.38
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med (2007) 1.35
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control (2005) 1.27
Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. Am J Respir Crit Care Med (2013) 1.24
Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ (2009) 1.24
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma. J Allergy Clin Immunol (2009) 1.23
Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. Respir Med (2013) 1.19
Factors associated with the appropriate use of asthma drugs. Can Respir J (2011) 1.18
Evaluation of a program aimed at increasing referrals for asthma education of patients consulting at the emergency department for acute asthma. Chest (2004) 1.16
Management of acute asthma in adults in the emergency department: assisted ventilation. CMAJ (2009) 1.16
The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. J Allergy Clin Immunol (2003) 1.13
Predictors of clustering of tuberculosis in Greater Vancouver: a molecular epidemiologic study. CMAJ (2002) 1.12
Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I. J Allergy Clin Immunol (2007) 1.10
Does this patient with liver disease have cirrhosis? JAMA (2012) 1.09
Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008. J Allergy Clin Immunol (2008) 1.08
Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report. Chest (2015) 1.07
Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes. Ann Allergy Asthma Immunol (2006) 1.06
What do we know about asthma triggers? a review of the literature. J Asthma (2012) 1.06
Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. PLoS One (2012) 1.05
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04
Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol (2002) 1.03
Pleural effusions following cardiac surgery: prevalence, risk factors, and clinical features. Chest (2009) 1.02
Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am J Respir Crit Care Med (2006) 1.02
Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg (2004) 1.00
The revised 2014 GINA strategy report: opportunities for change. Curr Opin Pulm Med (2015) 1.00
Canadian Thoracic Society: Presenting a new process for clinical practice guideline production. Can Respir J (2009) 1.00
Randomized trial of problem-based versus didactic seminars for disseminating evidence-based guidelines on asthma management to primary care physicians. J Contin Educ Health Prof (2004) 0.98
Variations and gaps in management of acute asthma in Ontario emergency departments. Chest (2008) 0.97
The coming of age of asthma guidelines. Lancet (2008) 0.96
Vocal cord dysfunction in bronchial asthma. A review article. J Asthma (2014) 0.96
Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada. Can Respir J (2010) 0.96
The determinants of prevalence of health complaints among young competitive swimmers. Int Arch Occup Environ Health (2006) 0.96
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast. J Asthma (2010) 0.95
Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med (2002) 0.95
Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. Can Respir J (2003) 0.95
The risk of death associated with delayed coronary artery bypass surgery. BMC Health Serv Res (2006) 0.94
The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Qual Life Res (2008) 0.94
CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population. Toxicol Sci (2012) 0.93
Understanding allergic asthma from allergen inhalation tests. Can Respir J (2007) 0.93
Technology, governance and patient safety: systems issues in technology and patient safety. Int J Med Inform (2006) 0.92
Do longer delays for coronary artery bypass surgery contribute to preoperative mortality in less urgent patients? Med Care (2006) 0.92
Inhaled allergen bronchoprovocation tests. J Allergy Clin Immunol (2013) 0.91
Respiratory health of elite athletes - preventing airway injury: a critical review. Br J Sports Med (2012) 0.90
Alveolar macrophage subpopulations in bronchoalveolar lavage and induced sputum of asthmatic and control subjects. J Asthma (2009) 0.89
Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults: executive summary. Can Respir J (2012) 0.89
Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.89
Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis. Otolaryngol Head Neck Surg (2009) 0.89
Symposium on obesity and asthma - November 2, 2006. Can Respir J (2007) 0.89
Diffuse panbronchiolitis in a Caucasian man in Canada. Can Respir J (2003) 0.89
Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89